Durga Prasanna Kumar CH

Title: Durga Prasanna Kumar CH: Innovator in Therapeutic Compounds

Introduction

Durga Prasanna Kumar CH is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target critical cellular processes. His work is aimed at addressing various diseases that affect cellular growth and function.

Latest Patents

Durga Prasanna Kumar CH holds a patent for "Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors." This patent describes novel compounds of the general Formula (I), including their analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites, and prodrugs. These compounds are designed to inhibit both LSD and HDAC, making them useful as therapeutic agents for diseases such as malignant tumors, schizophrenia, Alzheimer's disease, and Parkinson's disease.

Career Highlights

He is currently associated with Jubilant Epicore LLC, where he continues to innovate and develop new therapeutic solutions. His expertise in medicinal chemistry has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Durga Prasanna Kumar CH has collaborated with notable colleagues, including Sridharan Rajagopal and Mahanandeesha S Hallur. These collaborations have further enhanced his research and development efforts in the field of therapeutic compounds.

Conclusion

Durga Prasanna Kumar CH is a distinguished inventor whose work in developing dual inhibitors has the potential to significantly impact the treatment of various diseases. His contributions to medicinal chemistry are noteworthy and reflect his commitment to advancing healthcare solutions.